Personalized Medicine in Parkinson’s Treatment: Tailoring Therapies to Genetic and Symptom Profiles
Personalized medicine is transforming PD care, moving beyond generic treatments to tailor therapies to genetic and symptom profiles. This shift enhances efficacy and reshapes the PD therapeutics market, as firms invest in tools to identify patient subgroups.
Genetic testing (LRRK2, GBA mutations) guides targeted therapies. Only 20% of high-income PD patients test genetically (2023 AJN study)....
0 Bình luận
0 Chia sẻ
996 Lượt xem
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)